Oscar Health (NYSE:OSCR) Insider Adam Mcananey Sells 1,852 Shares

Oscar Health, Inc. (NYSE:OSCR) insider Adam Mcananey sold 1,852 shares of Oscar Health stock in a transaction on Tuesday, December 2nd. The shares were sold at an average price of $16.59, for a total value of $30,724.68. Following the transaction, the insider directly owned 179,241 shares of the company’s stock, valued at approximately $2,973,608.19. The trade was a 1.02% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink.

Oscar Health Price Performance

Shares of OSCR traded up $0.07 during trading hours on Thursday, hitting $17.17. The stock had a trading volume of 7,739,499 shares, compared to its average volume of 14,589,065. The company’s fifty day moving average is $18.08 and its two-hundred day moving average is $16.93. The company has a debt-to-equity ratio of 0.67, a current ratio of 0.92 and a quick ratio of 0.92. Oscar Health, Inc. has a 52 week low of $11.20 and a 52 week high of $23.80. The stock has a market capitalization of $4.55 billion, a price-to-earnings ratio of -15.33 and a beta of 1.88.

Oscar Health (NYSE:OSCR) last announced its quarterly earnings results on Thursday, November 6th. The company reported ($0.53) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.55) by $0.02. The firm had revenue of $2.93 billion during the quarter, compared to the consensus estimate of $3.09 billion. Oscar Health had a negative net margin of 2.16% and a negative return on equity of 21.50%. The firm’s quarterly revenue was up 23.2% on a year-over-year basis. During the same period last year, the firm posted ($0.22) EPS. On average, analysts anticipate that Oscar Health, Inc. will post 0.69 EPS for the current year.

Institutional Trading of Oscar Health

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Farther Finance Advisors LLC raised its holdings in Oscar Health by 4,420.7% during the 3rd quarter. Farther Finance Advisors LLC now owns 1,311 shares of the company’s stock worth $25,000 after purchasing an additional 1,282 shares during the last quarter. LRI Investments LLC grew its position in shares of Oscar Health by 377.9% during the 2nd quarter. LRI Investments LLC now owns 1,233 shares of the company’s stock worth $26,000 after buying an additional 975 shares during the period. Jones Financial Companies Lllp raised its stake in shares of Oscar Health by 7,473.3% during the first quarter. Jones Financial Companies Lllp now owns 2,272 shares of the company’s stock worth $30,000 after buying an additional 2,242 shares during the last quarter. Strs Ohio acquired a new position in Oscar Health in the first quarter valued at approximately $30,000. Finally, Atlantic Union Bankshares Corp bought a new position in Oscar Health in the second quarter valued at approximately $33,000. 75.70% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

OSCR has been the topic of a number of research analyst reports. Weiss Ratings restated a “sell (d)” rating on shares of Oscar Health in a research report on Wednesday, October 8th. UBS Group increased their target price on Oscar Health from $11.00 to $12.00 and gave the stock a “sell” rating in a report on Friday, November 7th. Piper Sandler upgraded Oscar Health from a “neutral” rating to an “overweight” rating and raised their target price for the company from $13.00 to $25.00 in a research note on Tuesday, November 25th. Barclays upped their price target on shares of Oscar Health from $11.00 to $13.00 and gave the stock an “underweight” rating in a research report on Monday, November 10th. Finally, Wells Fargo & Company lowered their price objective on shares of Oscar Health from $14.00 to $11.00 and set an “underweight” rating for the company in a research report on Thursday, November 13th. One investment analyst has rated the stock with a Buy rating, five have assigned a Hold rating and five have issued a Sell rating to the company. Based on data from MarketBeat, Oscar Health has an average rating of “Reduce” and an average price target of $14.86.

About Oscar Health

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.